SLC2A1 and neoplasm: CRC cells achieve glucose dominance through GLUT1 overexpression and upregulation of glycolytic enzymes, compounded by aberrant vasculature-induced perfusion deficits, establishing steep intratumoral glucose gradients with the lowest concentrations in tumor cores (Figure 3).